Literature DB >> 26417696

Aspartic acid racemization reveals a high turnover state in knee compared with hip osteoarthritic cartilage.

J B Catterall1, R D Zura2, M P Bolognesi2, V B Kraus3.   

Abstract

OBJECTIVE: We investigated tissue turnover in healthy and osteoarthritic cartilage. We challenge long held views that osteoarthritis (OA) is dominated by a similar turnover process in all joints and present evidence that hip and knee cartilage respond very differently to OA.
METHODS: d- and l-Aspartate (Asp) were quantified for whole cartilage, collagen and non-collagenous components of cartilage obtained at the time of joint replacement. We computed the Asp racemization ratio (Asp-RR = d/d + l Asp), reflecting the proportion of old to total protein, for each component.
RESULTS: Compared with hip OA, knee OA collagen fibrils (P < 0.0001), collagen (P = 0.007), and non-collagenous proteins (P = 0.0003) had significantly lower age-adjusted mean Asp-RRs consistent with elevated protein synthesis in knee OA. Knee OA collagen had a mean hydroxyproline/proline (H/P) ratio of 1.2 consistent with the presence of type III collagen whereas hip OA collagen had a mean H/P ratio of 0.99 consistent with type II collagen. Based on Asp-RR, the relative age was significantly different in knee and hip OA (P < 0.0005); on average OA knees were estimated to be 30 yrs 'younger', and OA hips 10 yrs 'older' than non-OA.
CONCLUSIONS: The metabolic response to OA was strikingly different by joint site. Knee OA cartilage evinced an anabolic response that appeared to be absent in hip OA cartilage. These results challenge the long held view that OA cartilage is capable of only minimal repair and that collagen loss is irreversible.
Copyright © 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage turnover; Collagen; Osteoarthritis; Racemization

Mesh:

Substances:

Year:  2015        PMID: 26417696      PMCID: PMC4897591          DOI: 10.1016/j.joca.2015.09.003

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  34 in total

1.  Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid.

Authors:  Sarit-Sara Sivan; Ellen Wachtel; Eve Tsitron; Nico Sakkee; Frits van der Ham; Jeroen Degroot; Sally Roberts; Alice Maroudas
Journal:  J Biol Chem       Date:  2008-02-04       Impact factor: 5.157

2.  Dating silk by capillary electrophoresis mass spectrometry.

Authors:  Mehdi Moini; Kathryn Klauenberg; Mary Ballard
Journal:  Anal Chem       Date:  2011-09-13       Impact factor: 6.986

3.  Different racemization ratios in dentin from different locations within a tooth.

Authors:  S Ohtani
Journal:  Growth Dev Aging       Date:  1997

4.  The breakdown of collagen by chondrocytes.

Authors:  R W Jubb; H B Fell
Journal:  J Pathol       Date:  1980-03       Impact factor: 7.996

5.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

6.  Protein modification by deamidation indicates variations in joint extracellular matrix turnover.

Authors:  Jonathan B Catterall; Ming F Hsueh; Thomas V Stabler; Christopher R McCudden; Michael Bolognesi; Robert Zura; Joanne M Jordan; Jordan B Renner; Sheng Feng; Virginia B Kraus
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

Review 7.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

8.  Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

Authors:  J Saklatvala; L M Pilsworth; S J Sarsfield; J Gavrilovic; J K Heath
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

9.  Evidence for altered synthesis of type II collagen in patients with osteoarthritis.

Authors:  F Nelson; L Dahlberg; S Laverty; A Reiner; I Pidoux; M Ionescu; G L Fraser; E Brooks; M Tanzer; L C Rosenberg; P Dieppe; A Robin Poole
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence.

Authors:  D R Eyre; M A Weis
Journal:  Osteoarthritis Cartilage       Date:  2009-03-05       Impact factor: 6.576

View more
  5 in total

Review 1.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

Authors:  V B Kraus; F J Blanco; M Englund; M A Karsdal; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2015-04-09       Impact factor: 6.576

2.  Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

Authors:  Soyun M Hwang; Marina Feigenson; Dana L Begun; Lomeli Carpio Shull; Kirsty L Culley; Miguel Otero; Mary B Goldring; Lauren E Ta; Sanjeev Kakar; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Orthop Res       Date:  2017-11-28       Impact factor: 3.494

Review 3.  Post-traumatic osteoarthritis of the ankle: A distinct clinical entity requiring new research approaches.

Authors:  Michelle L Delco; John G Kennedy; Lawrence J Bonassar; Lisa A Fortier
Journal:  J Orthop Res       Date:  2016-11-08       Impact factor: 3.494

4.  Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.

Authors:  Adam M Taylor; Ming-Feng Hsueh; Lakshminarayan R Ranganath; James A Gallagher; Jane P Dillon; Janet L Huebner; Jon B Catterall; Virginia B Kraus
Journal:  Rheumatology (Oxford)       Date:  2016-10-07       Impact factor: 7.580

5.  Analysis of "old" proteins unmasks dynamic gradient of cartilage turnover in human limbs.

Authors:  Ming-Feng Hsueh; Patrik Önnerfjord; Michael P Bolognesi; Mark E Easley; Virginia B Kraus
Journal:  Sci Adv       Date:  2019-10-09       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.